Atlas Trials

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

Clinical trial NCT02724904 · WITHDRAWN

Trial details

NCT number
NCT02724904
Sponsor
Massachusetts General Hospital
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2017-05-01
Primary completion
2019-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.